|
Teva Announces Positive Phase III GALA Study Results
A New Jersey federal judge ordered Merck & Co. to hand over purportedly privileged documents produced for government investigations concerning Vioxx (rofecoxib) — a partial discovery win for multidistrict litigation plaintiffs accusing the company of inflating its stock through misrepresentations about the recalled arthritis medication.
Pharmaceutical Business Review |
Register Now
Archives